School of Medicine
Showing 101-200 of 529 Results
-
Paul C Tang
Other Teaching Staff-Hourly, Medicine - Primary Care and Population Health
BioDr. Tang is Adjunct Professor in the Clinical Excellence Research Center at Stanford University and a practicing internist at the Palo Alto Medical Foundation. Most recently, he was Vice President, Chief Health Transformation Officer at IBM Watson Health. He has served in executive administration roles in health systems for over 25 years. Prior to joining Watson Health, Dr. Tang was Vice President, Chief Innovation and Technology Officer at the Palo Alto Medical Foundation (PAMF), directing the David Druker Center for Health Systems Innovation, a disruptive innovation center focused on grand challenges in health. Dr. Tang led one of the earliest implementations of an Electronic Health Record (EHR) system in the country in 1996, and in 2000, he co-developed MyChart, the first commercial patient portal, with Epic.
Dr. Tang is an elected member of the National Academy of Medicine, and has served on numerous NAM study committees, including a patient-safety committee he chaired that published two reports: Patient Safety: A New Standard for Care, and Key Capabilities of an Electronic Health Record System. He is a member of the Health and Medicine Division committee of the National Academies of Science, Engineering, and Medicine. Dr. Tang was co-chair of the federal Health Information Technology Policy committee from 2009-2017. He has served as board chair for several health informatics professional associations, including the American Medical Informatics Association (AMIA). He has served on the boards of AMIA, National Quality Forum, AcademyHealth, Computer-based Patient Record Institute, Joint Health Information Technology Alliance, NAM Board on Health Care Services, and National eHealth Collaborative. Dr. Tang is a recipient of the Nicholas E. Davies Award for Excellence in Computer-based Patient Record System Implementation, and the AMIA Don E. Detmer Award for Health Policy Contributions in Informatics. He currently holds one patent and has 16 patents pending. He has published numerous papers in medical informatics, appearing in New England Journal of Medicine, JAMA, Health Affairs, Annals of Internal Medicine, and Journal of the American Medical Informatics Association. Dr. Tang is a Fellow of the American College of Physicians, the American College of Medical Informatics, the College of Healthcare Information Management Executives, and the Healthcare Information and Management Systems Society.
He received his B.S. and M.S. in Electrical Engineering from Stanford University and his M.D. from the University of California, San Francisco. He completed his residency in internal medicine at Stanford University and is a board-certified practicing internist at the Palo Alto Medical Foundation. -
Sindy Tang
Associate Professor of Mechanical Engineering, Senior Fellow at the Woods Institute for the Environment and Professor, by courtesy, of Radiology and of Bioengineering
Current Research and Scholarly InterestsProf. Sindy K.Y. Tang develops engineering platforms that measure biological systems and convert these measurements into quantitative datasets. Her research focuses on experimental systems that probe biological processes across cellular and tissue scales, particularly how physical context—geometry, mechanics, and spatial organization—shapes biological function. Current work spans immune diagnostics, spatial tissue sampling for multi-omics analysis, and single-cell perturbation studies.
-
Sami Gamal-Eldin Tantawi
Professor of Particle Physics and Astrophysics, Emeritus
BioFor over a decade I have advocated for dedicated research efforts on the basic physics of room temperature high gradient structures and new initiatives for the associated RF systems. This required demanding multidisciplinary collaboration to harness limited resources. The basic elements of the research needed to be inclusive to address not only the fundamentals of accelerator structures but also the fundamentals of associated technologies such as RF manipulation and novel microwave power sources. These basic research efforts were not bundled with specific developments for an application or a general program. The emerging technologies promise a broad, transformational impact.
With this underlying philosophy in mind, in 2006 the US High Gradient Research Collaboration for which I am the spokesman was formed. SLAC is the host of this collaboration, which comprises MIT, ANL, University of Maryland and University of Colorado, NRL and a host of SBIR companies. This led to the revitalization of this research area worldwide. The international collaborative effort grew to include KEK in Japan, INFN, Frascati in Italy, the Cockcroft Institute in the UK, and the CLIC team at CERN.
This effort led to a new understanding of the geometrical effects affecting high gradient operations. The collaborative work led to new advances in understanding the gradient limits of photonic band gap structures. Now we have a new optimization methodology for accelerator structure geometries and ongoing research on alternate and novel materials. These efforts doubled the usable gradient in normal conducting high gradient linacs to more than 100 MV/m, thus revitalizing the spread of the technology to other applications including compact Inverse Compton Scattering gamma-ray sources for national security applications, and compact proton linacs for cancer therapy. -
Yun Tao
Student Svcs Offcr 1, Anesthesiology, Perioperative and Pain Medicine
Current Role at StanfordClerkship Program Coordinator
Department of Anesthesia
Stanford University School of Medicine -
Chris Tarver, MD, FAAPMR
Clinical Assistant Professor, Orthopaedic Surgery
Clinical Assistant Professor (By courtesy), Neurosurgery
Clinical Assistant Professor (By courtesy), Adult NeurologyBioDr. Tarver is board-certified in Physical Medicine and Rehabilitation and Brain Injury Medicine, with an emphasis on stroke rehabilitation. He is also a clinical assistant professor in the Department of Orthopaedic Surgery and a clinical assistant professor (by courtesy) in the Department of Neurosurgery and the Department of Neurology & Neurological Sciences at Stanford University School of Medicine. Dr. Tarver completed a PM&R residency at Loma Linda University Health. Prior to that, he received his Bachelor of Science in Biomedical Engineering and Doctor of Medicine degrees from Texas A&M University.
-
Peter Tass
Professor of Neurosurgery
BioDr. Peter Tass investigates and develops neuromodulation techniques for understanding and treating neurologic conditions such as Parkinson’s disease, epilepsy, dysfunction following stroke and tinnitus. He creates invasive and non-invasive therapeutic procedures by means of comprehensive computational neuroscience studies and advanced data analysis techniques. The computational neuroscience studies guide experiments that use clinical electrophysiology measures, such as high density EEG recordings and MRI imaging, and various outcome measures. He has pioneered a neuromodulation approach based on thorough computational modelling that employs dynamic self-organization, plasticity and other neuromodulation principles to produce sustained effects after stimulation. To investigate stimulation effects and disease-related brain activity, he focuses on the development of stimulation methods that cause a sustained neural desynchronization by an unlearning of abnormal synaptic interactions. He also performs and contributes to pre-clinical and clinical research in related areas.
-
Steven Tate
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr. Steven Tate serves as a Clinical Associate Professor specializing in addiction medicine within the Department of Psychiatry & Behavioral Sciences at Stanford University School of Medicine. He earned his medical degree from the University of Chicago and his master's in medical statistics from the London School of Hygiene and Tropical Medicine. He then completed his internal medicine residency at the University of Pennsylvania and his fellowship in addiction medicine at Stanford. Dr. Tate sees patients in the Stanford Addiction Medicine/Dual Diagnosis Clinic and in the hospital on the Inpatient Addiction Medicine Consult Service. He is interested in teaching evidence-based addiction medicine and translating evidence into practice to improve the care of patients with substance use disorders.
-
Tyler Patrick Tate
Clinical Associate Professor, Pediatrics
BioTyler Tate, MD, MA, is a pediatric palliative care physician, ethicist, and researcher at Stanford. His research interests include suffering and flourishing, love and emotions, religion and bioethics, pediatric ethics, and the medical humanities. He practices pediatric palliative care and serves as a clinical ethicist at Lucile Packard Children’s Hospital at Stanford. He is also core faculty in the Laurie J. Girand Center for Biomedical Ethics (GCBE). Prior to coming to Stanford he was an assistant professor at Oregon Health and Science University in Portland, Oregon.
-
Pahnwat Tonya Taweesedt, MD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Sleep Medicine
BioDr. Pahnwat Taweesedt is a board-certified, fellowship-trained sleep specialist at Stanford Health Care. She is also a clinical instructor in the Department of Psychiatry and Behavioral Sciences, Division of Sleep Medicine at Stanford University School of Medicine.
Dr. Taweesedt specializes in diagnosing and treating sleep disorders such as obstructive sleep apnea (OSA) and central sleep apnea (CSA). She also treats obesity hypoventilation syndrome, a condition that causes breathing issues during sleep.
Her research focuses on sleep technology, the relationship between sleep and neurodevelopmental disorders, and sleep in the aging population. She has also studied medications for narcolepsy (a disorder that affects the brain’s ability to control sleep-wake cycles).
Dr. Taweesedt has contributed chapters to a variety of medical textbooks, including “Advances in Health and Disease” and “Vasculitis: From Diagnosis to Treatment.” She also serves as a reviewer for several peer-reviewed research journals, including Sleep Science and Practice, Healthcare, and Journal of Autism and Developmental Disorders.
Dr. Taweesedt is a member of the American College of Chest Physicians, American Thoracic Society, Sleep Tracker Task Force of World Sleep Society, and American Academy of Sleep Medicine. -
Daniel Tawfik
Assistant Professor of Pediatrics (Critical Care)
Current Research and Scholarly InterestsThe Tawfik lab studies the use of electronic health record metadata in identifying structures and processes that promote high quality healthcare. Our projects apply advanced analytical methods to large databases of primarily structured electronic health record data and EHR usage metadata.
-
Vivianne Tawfik
Associate Professor of Anesthesiology, Perioperative and Pain Medicine (Adult Pain)
Current Research and Scholarly InterestsMy overall research interest is to understand how the immune system interacts with the nervous system after injury to promote the transition from acute to chronic pain. In my clinical practice I care for patients with persistent pain that often occurs after minor trauma such as fracture or surgery. Using basic science approaches including whole system immune phenotyping with mass cytometry and genetic manipulation of peripheral and central immune cells, we seek to dissect the temporal and tissue-specific contribution of these cells to either promotion or inhibition of healing.
-
C. Barr Taylor
Member, Cardiovascular Institute
Current Research and Scholarly InterestsDr. Taylor is developing and evaluating innovative electronic and computer-assisted programs to make treatments, proven effective for treating various lifestyle and psychosocial problems, more cost-effective and available. He is also developing new models of evidence-based psychiatry care for eating, anxiety and depressive disorders.
-
Ryan Taylor, MD
Clinical Assistant Professor, Adult Neurology
BioDr. Taylor is a fellowship-trained neurologist and assistant professor in the Department of Neurology and Neurological Sciences, Memory Disorders Division. He provides patient care at the Stanford Center for Memory Disorders.
His areas of expertise include diagnosing and treating illnesses that impair thinking, memory, behavior, and speech. Dr. Taylor’s clinical focus includes Alzheimer’s disease, Lewy body disease, frontotemporal dementia, primary progressive aphasia, posterior cortical atrophy, Creutzfeldt-Jakob disease, autoimmune encephalitis and other rapidly progressive dementias. He works with patients and families to provide diagnostic clarity and individualized treatment plans.
Dr. Taylor’s academic and research interests combine clinical and scientific understandings of dementia with a philosophical inquiry into the structure of conscious experience. His original clinical research includes diverse topics, such as advances in diagnosing Creutzfeldt-Jakob disease and the clinical characterization of adult-onset hereditary dementias. Dr. Taylor has published work instrumental in identifying the potential role of fentanyl in a syndrome of sudden onset amnesia that emerged during the opioid crisis.
He has presented research at the American Academy of Neurology and published in peer-reviewed journals, including the Canadian Journal of Neurological Sciences and Methods in Molecular Biology. He has also published a chapter on the diagnosis and treatment of frontotemporal dementia and was a reviewer for Neurocase.
Dr. Taylor is a fellow of the Royal College of Physicians of Canada. He has taught residents and medical students clinical skills, neuroanatomy, neuro-imaging, and other subjects. He also has delivered Grand Rounds presentations on dementia, epilepsy, and pediatric neurology. -
David Tehrani, MD, MS
Affiliate,
BioDr. Tehrani is a board-certified, fellowship-trained interventional cardiologist with Stanford Health Care Tri-Valley in the East Bay.
He is focused on building long-term relationships with his patients and their families, while sharing his evidence-based expertise in the noninvasive and minimally invasive management of cardiovascular disease. He takes pride in forming care plans based on mutual decision-making.
Dr. Tehrani’s research interests include cutting-edge technology and advancements in medical management of cardiovascular disease. His clinical research studies and funded clinical research trials have focused on cardiovascular biomarkers, coronary physiology, cardiac hemodynamics, cardio-oncology, and procedural closure devices. His research background has been instrumental in helping him provide individualized, evidence-based care plans for conditions ranging from advanced heart failure to complex coronary disease.
Dr. Tehrani has an extensive clinical research background, with over 40 peer-reviewed publications in top cardiology journals. He has done over 30 presentations at conferences, including the American Heart Association (AHA) and American College of Cardiology (ACC) national meetings.
Dr. Tehrani is a member the American College of Cardiology, the American College of Physicians, the American Heart Association, the Heart Failure Society of America, and the International Society of Heart and Lung Transplantation. -
Nicholas Telischak, MD, MS
Clinical Associate Professor, Radiology
Clinical Associate Professor (By courtesy), NeurosurgeryBioA native of the Bay Area, Dr. Nick Telischak is a dual fellowship-trained neurointerventional surgeon and neuroradiologist at Stanford Health Care. With board certifications in radiology and neuroradiology, he serves as a clinical associate professor in the Department of Radiology, and, by courtesy of the Department of Neurosurgery, at Stanford School of Medicine.
Dr. Telischak specializes in diagnosing and treating artery disorders in the brain and spine, including brain aneurysms, arteriovenous malformations (AVM), and dural arteriovenous fistula (dAVF), and stroke. Dr. Telischak also specializes in venous disorders in the brain including idiopathic intracranial hypertension (IIH). He also has a special interest in pulsatile tinnitus, a whooshing sound in the ears that occurs in rhythm with the heartbeat. Dr. Telischak also treats painful spinal (vertebral) fractures, spinal metastases (tumors resulting from cancer elsewhere in the body), and congenital vascular malformations (blood vessel abnormalities that are present at birth). He treats these conditions using minimally invasive, image-guided procedures and state-of-the-art technology.
Prior to joining Stanford Health Care, Dr. Telischak helped develop the Stroke Program at California Pacific Medical Center and Mills-Peninsula Medical Center, giving him a broad perspective on medical care systems within the Bay Area.
Dr. Telischak’s research focuses on:
• Identifying biomarkers to diagnose large vessel occlusion stroke (stroke in one of the large arteries in the brain)
• Noninvasive MRI techniques for diagnosing idiopathic intracranial hypertension (high pressure within the skull)
He is also the principal investigator for a study examining the efficacy of vertebroplasty and kyphoplasty for the treatment of painful vertebral compression fractures.
In addition, Dr. Telischak holds a master’s degree in bioengineering. He has worked with several companies pioneering new devices to treat brain aneurysms, vascular malformations, and strokes caused by blood clots, as well as new treatments for venous disorders in the brain caused by idiopathic intracranial hypertension.
Dr. Telischak has published more than 20 peer-reviewed articles and has been invited to present locally, nationally, and internationally at meetings for the Society of NeuroInterventional Surgery, American Society of Neuroradiology, and Jornada de Stroke in Asuncion, Paraguay, where he has served as visiting faculty. -
Melinda L. Telli, M.D.
Professor of Medicine (Oncology)
Current Research and Scholarly InterestsMy research focuses on the development of novel therapies for the treatment of triple-negative and hereditary cancer. Other areas of interest include prevention of cardiac damage associated with breast cancer treatment and cardiotoxicity of anti-cancer agents.
-
Joyce Teng, MD, PhD
Professor of Dermatology and, by courtesy, of Pediatrics
BioJoyce Teng, MD, PhD is a professor in dermatology at Stanford University. She is affiliated with multiple hospitals in the area, including Lucile Salter Packard Children's Hospital (LPCH) at Stanford and Stanford Hospital and Clinics (SHC). She received her medical degree from Vanderbilt University School of Medicine and has been in practice for more than 12 years. She is one of the 6 pediatric dermatologists practicing at LPCH and one of 72 at SHC who specialize in Dermatology. She sees patients with rare genetic disorders, birthmarks, vascular anomalies and a variety of inflammatory skin diseases. She is also an experienced pediatric dermatological surgeon. Her research interests are drug discovery and novel therapy for skin disorders.
-
Nelson Teng
Professor of Obstetrics and Gynecology (Oncology), Emeritus
Current Research and Scholarly InterestsGynecologic Malignancies
Immunotherapy
Biologic Response Modifiers
New Drug Development
Antigenic specificities of human antibodies encoded by the VH4-34 gene -
Valerie Teng
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioDr. Valerie Teng is a board certified family physician with special interests in preventative medicine and women's health. Her experiences in caring for patients with chronic conditions, such as diabetes and hypertension, have fueled her desire to partner with patients to enter healthier lifestyles. She is also passionate about providing comprehensive care to patients of all ages, including newborns and teens.
During her residency training, Dr. Teng explored many opportunities in medical education through the O’Connor-Stanford Leaders in Education Residency (OSLER) program. She is delighted to continue in medical education as a part of the faculty at Stanford Family Medicine. -
Azusa Terasaki
Postdoctoral Scholar, Pathology
BioAzusa Terasaki, MD, PhD, is a Postdoctoral scholar in the Department of Pathology at Stanford University School of Medicine. Her research focuses on tumor immunology and cancer metabolism, with a particular interest in mitochondrial transfer between cancer and immune cells and its role in immune suppression and metastasis.
Dr. Terasaki received her medical degree and PhD in Japan, where she completed her surgical training and is a board-certified surgeon with additional certifications as a breast specialist and in cancer therapy. During her clinical career, she developed a strong interest in translational research that bridges fundamental discoveries and patient care.
Her current work investigates how cancer cells reprogram immune cells through organelle transfer, integrating imaging, flow cytometry, and multi-omic approaches to uncover novel mechanisms of tumor–immune interaction. Her goal is to identify new therapeutic targets and biomarkers to improve cancer treatment outcomes. -
Stefano Testa
Instructor, Medicine - Oncology
BioDr. Testa is a medical oncologist and physician-scientist specializing in cellular therapy and the care of patients with soft tissue and bone sarcomas. He earned his medical degree from the University of Naples Federico II in Naples, Italy. He subsequently moved to the United States and conducted research in the laboratory of Dr. Ronald Levy at Stanford University, where he studied intratumoral vaccination strategies and mRNA delivery platforms designed to target B cells and T cells in vivo. He completed his internal medicine residency at Stanford University, followed by a fellowship in hematology and oncology at Beth Israel Deaconess Medical Center. Dr. Testa’s research focuses on identifying targets for adoptive T-cell therapies in solid tumors, particularly soft tissue and bone sarcomas, and on novel synthetic biology approaches to enhance the effectiveness of T-cell therapies against solid tumors.
